| Biomarker ID | 1910 |
| PMID | 30396985 |
| Year | 2018 |
| Biomarker | HSP27; prohibitin; GSTP1; fibrinogen β chain; ALDH6A1; A1AT; HSP60; |
| Biomarker Basis | Expression Based |
| Biomolecule | Protein |
| Source | Tissue |
| Subjects | Humans |
| Regulation | Downregulated in Metastatic PCa |
| Odds Ratio/Hazard Ratio/Relative Risk | NA |
| Effect on Pathways | NA |
| Experiment | Metastatic Prostate Cancer Vs No Prostate Cancer |
| Type of Biomarker | Diagnostic |
| Cohort | 3 normal prostates, 3 localized prostate cancers, 2 bone metastatic prostate cancer were chosen for analysis |
| Senstivity | NA |
| Specificity | NA |
| AUC | NA |
| Accuracy | NA |
| Level Of Significance | NA |
| Method Used | Immunohistochemistry |
| Clinical | No |
| Remarks | NA |
| Clinical Trial Number | NA |
| Degree Of Validity | Validated on independent patient dataset |
| Technical Name | NA |